Professor Fabrizio Schifano

Research output

Research output per year 1983 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 248 Article
• 38 Review article
• 20 Editorial
• 11 Chapter
• 55 More
  • 11 Letter
  • 10 Meeting abstract
  • 5 Chapter (peer-reviewed)
  • 4 Conference contribution
  • 4 Poster
  • 4 Comment/debate
  • 3 Commissioned report
  • 2 Book
  • 2 Other report
  • 2 Paper
  • 2 Other contribution
  • 1 Entry for encyclopedia/dictionary
  • 1 Other chapter contribution
  • 1 Abstract
  • 1 Literature review
  • 1 Short survey
  • 1 Special issue

Research output per year

Research output per year

Search results

• 2017

  An international survey on the awareness, use, preference and health perception of Novel Psychoactive Substances (NPS)

  Deligianni, E., Corkery, J., Schifano, F. & Lione, L., 8 May 2017, In: Human Psychopharmacology: Clinical and Experimental. 32, 3, 9 p., e2581.

  Research output: Contribution to journal › Special issue › peer-review

  Open Access

  File

  • Health 100%
  • Education 64%
  • Social Media 63%
  • Sexual and Gender Minorities 52%
  • Administrative Personnel 52%
  5 Citations (Scopus)

  24 Downloads (Pure)

• Herbal Highs: Review on Psychoactive Effects and Neuropharmacology

  Graziano, S., Orsolini, L., Rotolo, M. C., Tittarelli, R., Schifano, F. & Pichini, S., 1 May 2017, In: Current Neuropharmacology. 15, 5, p. 750-761 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Neuropharmacology 100%
  • Ipomoea 39%
  • Convolvulaceae 39%
  • Datura stramonium 38%
  • Mitragyna 38%
  17 Citations (Scopus)

• New Psychoactive Substances (NPS) - A Challenge for the Addiction Treatment Services

  Scherbaum, N., Schifano, F. & Bonnet, U., 1 May 2017, In: Pharmacopsychiatry. 50, 3, p. 116-122 7 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Cannabinoids 100%
  • cathinone 67%
  • phenethylamine 66%
  • tryptamine 62%
  • Unconsciousness 50%
  18 Citations (Scopus)

  57 Downloads (Pure)

• Dramatic Changes Over Time of Methamphetamine Intake in a German, HIV-Positive, Sample of Men who have Sex with Men (MSM)

  Dirks, H., Esser, S., Brockmeyer, N., Bonnet, U., Schifano, F. & Scherbaum, N., May 2017, In: Pharmacopsychiatry. 50, 3, p. 123-124 2 p.

  Research output: Contribution to journal › Article › peer-review

  • Methamphetamine 100%
  • Sexual and Gender Minorities 87%
  • HIV 58%
  1 Citation (Scopus)

• Novel psychoactive substance consumption is more represented in bipolar disorder than in psychotic disorders: A multicenter-observational study

  Acciavatti, T., Lupi, M., Santacroce, R., Aguglia, A., Attademo, L., Bandini, L., Ciambrone, P., Lisi, G., Migliarese, G., Pinna, F., Quattrone, D., Ribolsi, M., Signorelli, M. S., Calò, S., Schifano, F., di Giannantonio, M. & Martinotti, G., May 2017, In: Human Psychopharmacology: Clinical and Experimental. 32, 3, 6 p., e2578.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Bipolar Disorder 100%
  • Psychotic Disorders 96%
  • Multicenter Studies 89%
  • Observational Studies 80%
  • Psychiatry 76%
  10 Citations (Scopus)

  19 Downloads (Pure)

• Cannabis; epidemiological, neurobiological and psychopathological issues: an update

  De Luca, M. A., Di Chiara, G., Cadoni, C., Lecca, D., Orsolini, L., Papanti, D., Corkery, J. & Schifano, F., 13 Apr 2017, (E-pub ahead of print) In: CNS & Neurological Disorders - Drug Targets. 16

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Cannabis 100%
  • Social Perception 14%
  • Pharmaceutical Preparations 12%
  • Social Responsibility 12%
  • Psychotropic Drugs 12%
  17 Citations (Scopus)

  70 Downloads (Pure)

• Is there a teratogenicity risk associated with cannabis and synthetic cannabimimetics’ (’Spice’) intake?

  Orsolini, L., Papanti, D., Corkery, J., De Luca, M. A., Cadoni, C., Di Chiara, G. & Schifano, F., 13 Apr 2017, (E-pub ahead of print) In: CNS & Neurological Disorders - Drug Targets. 16

  Research output: Contribution to journal › Article › peer-review

  • Spices 100%
  • Cannabis 79%
  • Pregnancy 32%
  • Endocannabinoids 26%
  • Organogenesis 13%
  8 Citations (Scopus)

• Symptoms of drug abuse in the workplace

  Schifano, F., 1 Jan 2017, Addiction at Work: Tackling Drug Use and Misuse in the Workplace. Taylor & Francis Group, p. 53-68 16 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Illicit Drugs 100%
  • Drug Abuse 96%
  • Construction Industry 94%
  • Employee Assistance Programs 89%
  • Drug Use 88%
• 2016

  Use of benzylglycinamide by a HIV-seropositive polysubstance user: the changing pattern of novel psychoactive substance use among youths

  Caloro, M., Calabro, G., Kotzalidis, G. D., Cuomo, I., Corkery, J. M., Vento, A. E., Lionetto, L., De Filippis, S., Ranieri, V., Lonati, D., Locatelli, C. A., de Pisa, E., Di Tommaso, A., Girardi, P. & Schifano, F., 30 Sept 2016, In: Addictive Behaviors. 60, p. 53-57 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Cannabinoids 100%
  • psychosis 99%
  • Psychotic Disorders 80%
  • Psychotropic Effect 79%
  • abuse 64%
  1 Citation (Scopus)

  75 Downloads (Pure)

• Substance use and misuse - Legal highs

  Guirguis, A., Gittins, R., Corkery, J. & Schifano, F., 21 Sept 2016, 3 p. UK : Centre for Pharmacy Post Graduate Education (CPPE).

  Research output: Other contribution

  • pharmacist 100%
  • public health 64%
  • graduate 56%

• Novel Psychoactive Substances: the pharmacology of stimulants and hallucinogens

  Schifano, F., Papanti, D., Orsolini, L. & Corkery, J., 2 Jul 2016, In: Expert Review of Clinical Pharmacology. 9, 7, p. 943-54 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hallucinogens 100%
  • Rhabdomyolysis 90%
  • Neurotransmitter Receptor 88%
  • Cannabinoids 84%
  • Propofol 77%
  30 Citations (Scopus)

  72 Downloads (Pure)

• A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency’s ‘Suspected Adverse Drug Reactions’ Database

  Chiappini, S. & Schifano, F., 16 Jun 2016, (E-pub ahead of print) In: Drugs. 30, 7, p. 647-654 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Pharmaceutical Databases 100%
  • Pregabalin 96%
  • Gabapentin 89%
  • Drug-Related Side Effects and Adverse Reactions 65%
  • Substance-Related Disorders 24%
  83 Citations (Scopus)

  34 Downloads (Pure)

• NPS: Medical Consequences Associated with Their Intake

  Schifano, F., Orsolini, L., Papanti, D. & Corkery, J., 7 Jun 2016, Neuropharmachology of New Psychoactive Substances (NPS): The Science Behind the Headlines. Baumann, M. H., Glennon, R. A. & Wiley, J. L. (eds.). Springer Nature Link, Vol. 32. p. 351-380 30 p. (Current Topics in Behavioral Neurosciences; vol. 32, no. 1).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter (peer-reviewed) › peer-review

  • cathinone 100%
  • Phenethylamines 98%
  • Hallucinogens 88%
  • Cannabinoids 74%
  • Pharmaceutical Preparations 52%
  20 Citations (Scopus)

• Gli Psiconauti: navigatori della mente o sperimentatori chimici?

  Translated title of the contribution: The Psychonauts: mind’s navigators or chemical experimenters?Orsolini, L., Vecchiotti, R., Papanti, D., Valchera, A., Corkery, J. & Schifano, F., 1 Jun 2016, In: Medicina delle Dipendenze. 6, 22, p. 15-21 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Blogs 100%
  • Experimenter 93%
  • Social Networks 90%
  • Giovani 72%
  • Trip 40%

• Le nuove sostanze psicoattive: problematiche cliniche e farmacologiche

  Translated title of the contribution: The novel psychoactive substances: clinical and pharmacological issuesSchifano, F., Orsolini, L., Papanti, D. & Corkery, J., 1 Jun 2016, In: Medicina delle Dipendenze. 6, 22, p. 5-14 10 p.

  Research output: Contribution to journal › Article › peer-review

• Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135

  De Luca, M. A., Castelli, M. P., Loi, B., Porcu, A., Martorelli, M., Miliano, C., Kellett, K., Davidson, C., Stair, J. L., Schifano, F. & Di Chiara, G., 1 Jun 2016, In: Neuropharmacology. 105, p. 630-638 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide 100%
  • cannabinoid K2 94%
  • N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide 94%
  • 1-pentyfluoro-1H-indole-3-carboxylic acid 8-quinolinyl ester 93%
  • 1-pentyl-3-(1-naphthoyl)indole 65%
  48 Citations (Scopus)

  57 Downloads (Pure)

• The characteristics of deaths involving kratom in the United Kingdom and elsewhere

  Corkery, J., Claridge, H., Goodair, C., Papanti, D., Orsolini, L., Koerber, S. & Schifano, F., 31 May 2016, In: Research and Advances in Psychiatry (RAP). 2, 3-4, p. 103 1 p., PS5.6.

  Research output: Contribution to journal › Meeting abstract › peer-review

• The consequences of drug misuse on post-marketing surveillance

  Schifano, F., Papanti, D., Orsolini, L. & Corkery, J., 25 Apr 2016, In: Expert Review of Clinical Pharmacology. 9, 7, p. 867-871 5 p.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access

  • Drug Misuse 100%
  • Marketing 74%
  • Pharmaceutical Preparations 28%
  • Prescription Drugs 27%
  • Benzodiazepines 23%
  12 Citations (Scopus)

• An evaluation of the types and contributing factors of dispensing errors in hospital pharmacy

  Aldhwaihi, K., Schifano, F., Pezzolesi, C. & Umaru, N., 18 Mar 2016. 1 p.

  Research output: Contribution to conference › Poster › peer-review

  Open Access

  File
  38 Downloads (Pure)

• Is addiction medicine part of psychiatry?

  Orsolini, L., Papanti, D., Valchera, A., Vecchiotti, R., Corkery, J. & Schifano, F., 1 Mar 2016, In: European Psychiatry. 33, Supplement, p. S15 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

  • Addiction Medicine 100%
  • Psychiatry 48%
  • Dual (Psychiatry) Diagnosis 11%
  • Gambling 10%
  • Respect 8%

• Novel psychoactive substances

  Orsolini, L., Papanti, D., Vecchiotti, R., Valchera, A., Corkery, J. & Schifano, F., Mar 2016, In: European Psychiatry. 33, p. S59-60 2 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Le nuove sostanze psicoattive: aspetti epidemiologici, clinici e farmacologici

  Translated title of the contribution: New psychoactive substances: epidemiological, clinical and pharmacological aspectsSchifano, F., Orsolini, L., Papanti, D. & Corkery, J., Feb 2016, Psicologia e psicopatologia delle dipendenze e dei comportamenti di abuso. Girardi, P. & di Giannantino, M. (eds.). Pisa, Italy: Casa Editrice Pacini, p. 147-167

  Research output: Chapter in Book/Report/Conference proceeding › Entry for encyclopedia/dictionary

• A systematic review of the nature of dispensing errors in hospital pharmacies

  Aldhwaihi, K., Schifano, F., Pezzolesi, C. & Umaru, N., 12 Jan 2016, In: Integrated Pharmacy Research and Practice. 5, p. 1-10

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Pharmacies 100%
  • Systematic Reviews 64%
  • Research Personnel 24%
  • Cohort Studies 23%
  • Dosage Forms 19%
  33 Downloads (Pure)

• The potential utility of some legal highs in CNS disorders

  Davidson, C. & Schifano, F., 4 Jan 2016, In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 64, p. 267-274 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • Substance-Related Disorders 100%
  • Pharmacology 75%
  • Pharmaceutical Preparations 70%
  • Explosions 69%
  • Molecular Structure 68%
  8 Citations (Scopus)
• 2015

  Case study: Assessing and counselling a patient with insomnia

  Schifano, F., Oct 2015, In: Clinical Pharmacist. 7, 9

  Research output: Contribution to journal › Article › peer-review

• Deaths of individuals aged 16-24 years in the UK after using mephedrone

  Loi, B., Corkery, J., Claridge, H., Goodair, C., Chiappini, S., Gimeno Clemente, C. & Schifano, F., 28 Jul 2015, In: Human Psychopharmacology: Clinical and Experimental. 30, 4, p. 225-232 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • mephedrone 100%
  • Coroners and Medical Examiners 22%
  • Amphetamine 18%
  • Pharmaceutical Preparations 14%
  • Islands 9%
  37 Citations (Scopus)

  390 Downloads (Pure)

• Methoxetamine-related deaths in the UK: an overview

  Chiappini, S., Claridge, H., Corkery, J., Goodair, C., Loi, B. & Schifano, F., 28 Jul 2015, In: Human Psychopharmacology: Clinical and Experimental. 30, 4, p. 244-248 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone 100%
  • Coroners and Medical Examiners 19%
  • Guernsey 14%
  • Islands 8%
  • Poisoning 7%
  24 Citations (Scopus)

  409 Downloads (Pure)

• Profiling online recreational/prescription drugs' customers and overview of drug vending virtual marketplaces

  Orsolini, L., Francesconi, G., Papanti, D., Giorgetti, A. & Schifano, F., 28 Jul 2015, In: Human Psychopharmacology: Clinical and Experimental. 30, 4, p. 302-18 17 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Prescription Drugs 100%
  • Illicit Drugs 94%
  • Marketing 36%
  • Pharmaceutical Preparations 35%
  • Online Pharmaceutical Services 31%
  46 Citations (Scopus)

  18 Downloads (Pure)

• Venlafaxine as the ‘baby ecstasy’? Literature overview and analysis of web-based misusers’ experiences

  Francesconi, G., Orsolini, L., Corkery, J., Papanti, D. & Schifano, F., 28 Jul 2015, In: Human Psychopharmacology: Clinical and Experimental. 30, 4, p. 255-261 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Venlafaxine Hydrochloride 100%
  • Hallucinogens 17%
  • N-Methyl-3,4-methylenedioxyamphetamine 16%
  • Pharmaceutical Preparations 15%
  • Illicit Drugs 13%
  13 Citations (Scopus)

• Effects of ketamine on psychomotor, Sensory and cognitive functions relevant for driving ability

  Giorgetti, R., Marcotulli, D., Tagliabracci, A. & Schifano, F., 1 Jul 2015, In: Forensic Science International. 252, p. 127-142 16 p.

  Research output: Contribution to journal › Review article › peer-review

  • traffic accident 100%
  • Ketamine 85%
  • Cognition 61%
  • Aptitude 52%
  • pharmacology 47%
  27 Citations (Scopus)

• Olanzapine as the ideal ‘trip terminator’? Analysis of online reports relating to antipsychotics’s use and misuse following occurance of novel psychoactive substance-related psychotic symptoms

  Valeriani, G., Corazza, O., Bersani, F. S., Melcore, C., Metastasio, A., Bersani, G. & Schifano, F., Jul 2015, In: Human Psychopharmacology: Clinical and Experimental. 30, 4, p. 249-254

  Research output: Contribution to journal › Article › peer-review

  • Olanzapine 100%
  • Substance-Induced Psychoses 65%
  • Self-Management 44%
  • Pharmacology 27%
  25 Citations (Scopus)

• Survey of knowledge of legal highs (novel psychoactive substances) amongst London pharmacists

  Guirguis, A., Corkery, J., Stair, J., Kirton, S., Zloh, M., Goodair, C., Schifano, F. & Davidson, C., 1 Jun 2015, In: Drugs and Alcohol Today. 15, 2, p. 93-99 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • pharmacist 100%
  • Pharmacists 88%
  • Pharmacies 22%
  • Continuing Education 12%
  • event 11%
  6 Citations (Scopus)

  289 Downloads (Pure)

• Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4 butanediol (1,4-BD; BDO): a literature review with a focus on UK fatalities related to non-medical use

  Corkery, J., Loi, B., Claridge, H., Goodair, C., Corazza, O., Elliott, S. & Schifano, F., Jun 2015, In: Neuroscience and Biobehavioral Reviews. 53, p. 52-78

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • 1,4-butanediol 100%
  • 4-Butyrolactone 90%
  • Sodium Oxybate 84%
  • Alcohols 25%
  • Drug Misuse 16%
  51 Citations (Scopus)

  2688 Downloads (Pure)

• Role of patient-reported outcomes and other efficacy endpoints in the drug approval process in Europe (2008-2012)

  Bansal, D., Bhagat, A., Schifano, F. & Gudala, K., 29 May 2015, In: Journal of Epidemiology and Global Health. 5, 4, p. 385-395 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Drug Approval 100%
  • Patient Reported Outcome Measures 85%
  • Naphazoline 13%
  • Marketing 10%
  • Antineoplastic Agents 9%
  10 Citations (Scopus)

  15 Downloads (Pure)

• Mind Navigators of Chemicals' Experimenters? A Web-Based Description of E-Psychonauts

  Orsolini, L., Papanti, G. D., Francesconi, G. & Schifano, F., 12 May 2015, In: Cyberpsychology, Behavior, and Social Networking. 18, 5, p. 296-300 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Blogs 100%
  • drug 57%
  • Pharmaceutical Preparations 34%
  • Blogging 18%
  • Hallucinogens 16%
  45 Citations (Scopus)

• Novel psychoactive substances (NPS): Clinical and pharmacological issues

  Schifano, F., 2 Mar 2015, In: Drugs and Alcohol Today. 15, 1, p. 21-27 7 p.

  Research output: Contribution to journal › Article › peer-review

  • clinical management 100%
  • health professionals 97%
  • pharmacology 86%
  • Pharmacology 69%
  • Piperazines 63%
  7 Citations (Scopus)

• Novel psychoactive substances of interest for psychiatry

  Schifano, F., Orsolini, L., Papanti, D. & Corkery, J., Feb 2015, In: World Psychiatry: official journal of the World Psychiatric Association (WPA). 14, 1, p. 15-26 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Cannabinoids 100%
  • Piperazines 78%
  • cathinone 67%
  • GABA-B Receptor Agonists 67%
  • Phenethylamines 66%
  159 Citations (Scopus)

  259 Downloads (Pure)

• Novel psychoactive substances and induced phenomena in psychopathology: The lysergic psychoma

  Martinotti, G., Di Nicola, M., Quattrone, D., Santacroce, R., Schifano, F., Murray, R. & Di Giannantonio, M., 1 Jan 2015, In: Journal of Psychopathology. 21, 4, p. 400-405 6 p.

  Research output: Contribution to journal › Article › peer-review

  • cyclonite 100%
  • Narcotics 64%
  • psychopathology 55%
  • Psychopathology 55%
  • Substance-Induced Psychoses 44%
  8 Citations (Scopus)

• The “Eyeballing” technique: an emerging and alerting trend of alcohol misuse

  Bersani, S., Corazza, O., Albano, G., Bruschi, S., Minichino, A., Vicinanza, R., Bersani, G., Martinotti, G. & Schifano, F., 2015, In: European Review for Medical and Pharmacological Sciences . 19, 12, p. 2311-2317

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Alcohols 100%
  • Alcohol Drinking 61%
  • Substance-Related Disorders 58%
  • Young Adult 53%
  • Epithelium 50%
  5 Citations (Scopus)

  15 Downloads (Pure)
• 2014

  The diffusion of Performance and Image Enhancing Drugs (PIEDs) on the internet: The abuse of the cognitive enhancer Piracetam

  Corazza, O., Bersani, S., Brunoro, R., Valeriani, G., Martinotti, G. & Schifano, F., 6 Dec 2014, In: Substance Use and Misuse. 49, 14, p. 1849-1856

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Performance-Enhancing Substances 100%
  • Piracetam 99%
  • Nootropic Agents 93%
  • Internet 64%
  • abuse 49%
  36 Citations (Scopus)

  122 Downloads (Pure)

• A systematic review of counterfeit and substandard medicines in field quality surveys

  Alghannam, A., Aslanpour, Z., Evans, S. & Schifano, F., Sept 2014, In: Integrated Pharmacy Research and Practice. 3, p. 71-88

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Substandard Drugs 100%
  • Counterfeit Drugs 92%
  • Systematic Reviews 41%
  • Medicine 40%
  • Public Health 19%
  982 Downloads (Pure)

• Neue psychotrope Substanzen - "legal Highs"

  Translated title of the contribution: New psychotropic drugs - "legal highs"Scherbaum, N., Schifano, F. & Siemann, H., Sept 2014, In: Fortschritte der Neurologie Psychiatrie. 82, 9, p. 532-543 12 p.

  Research output: Contribution to journal › Article › peer-review
  4 Citations (Scopus)

• Substance use in the club scene of Rome: a pilot study

  Vento, A., Martinotti, G., Cinosi, E., Lupi, M., Acciavatti, T., Carrus, D., Santacroce, R., Chillemi, E., Bonifaci, L., di Giannantonio, M., Corazza, O. & Schifano, F., 28 Aug 2014, In: BioMed Research International. 2014, 5 p., 617546.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Illicit Drug 100%
  • Illicit Drugs 54%
  • Pharmacological Effect 47%
  • Cocaine 44%
  • Drug 38%
  19 Citations (Scopus)

  155 Downloads (Pure)

• Noids in a nutshell: Everything you (don’t) want to know about synthetic cannabimimetics

  Papanti, D., Orsolini, L., Francesconi, G. & Schifano, F., 12 Aug 2014, In: Advances in Dual Diagnosis. 7, 3, p. 137-148 12 p.

  Research output: Contribution to journal › Review article › peer-review

  • Dronabinol 100%
  • Hallucinations 91%
  • Cannabis 85%
  • Designer Drugs 61%
  • Mydriasis 56%
  20 Citations (Scopus)

• 25C-NBOMe: preliminary data on pharmacology, psychoactive effects and toxicity of a new potent hallucinogenic drug

  Bersani, F. S., Corazza, O., Albano, G., Valeriani, G., Santacroce, R., Bolzan, F., Cinosi, E., Simonato, P., Martinotti, G., Bersani, G. & Schifano, F., 3 Jul 2014, In: BioMed Research International. 2014, 6 p., 734749.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • 2-(4-chloro-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine 100%
  • Psychodysleptic Agent 82%
  • Sublingual 79%
  • Hallucinogens 66%
  • Partial Agonist 61%
  71 Citations (Scopus)

  831 Downloads (Pure)

• Emerging drugs in Europe

  Papaseit, E., Farré, M., Schifano, F. & Torrens, M., 1 Jul 2014, In: Current Opinion in Psychiatry. 27, 4, p. 243-250 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • cathinone 100%
  • Cannabinoids 74%
  • Piperazines 58%
  • Phenethylamines 49%
  • Tryptamines 45%
  38 Citations (Scopus)

• Monitoring novel psychoactive substances allegedly offered online for sale in Persian and Arabic languages

  Corazza, O., Assi, S., Malekianragheb, S., Beni, M., Bigdeli, I., Aslanpour, Z. & Schifano, F., 1 Jul 2014, In: International Journal of Drug Policy. 25, 4, p. 724-726 3 p.

  Research output: Contribution to journal › Article › peer-review

  • sale 100%
  • search engine 92%
  • website 80%
  • Language 79%
  • monitoring 72%
  7 Citations (Scopus)

• An evaluation of dispensing errors at King Saud Medical City pharmacies.

  Aldhwaihi, K., Schifano, F., Pezzolesi, C. & Umaru, N., 23 Jun 2014, 4th International Conference on Healthcare Systems Ergonomics and Patient Safety, Taiwan, 23-26 June 2014. .

  Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

• Sexual enhancement products for sale online: raising awareness of the psychoactive effects of Yohimbine, Maca, Horny Goat Weed and Ginkgo Biloba

  Corazza, O., Martinotti, G., Santacroce, R., Chilemi, E., Schifano, F. & Cellek, S., 15 Jun 2014, In: BioMed Research International. 2014, 13 p., 841798.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Lepidium 100%
  • Yohimbine 84%
  • Ginkgo biloba 81%
  • Goats 63%
  • Dietary Supplements 59%
  31 Citations (Scopus)

  761 Downloads (Pure)

• Misuse and abuse of pregabalin and gabapentin: Cause for concern?

  Schifano, F., Jun 2014, In: CNS Drugs. 28, 6, p. 491-496 6 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Pregabalin 100%
  • Gabapentin 92%
  • Illicit Drugs 20%
  • Calcium Channels 19%
  • Neurology 19%
  136 Citations (Scopus)